Rockwell Medical Inc (RMTI)
1.51
+0.02
(+1.34%)
USD |
NASDAQ |
Apr 25, 16:00
1.50
-0.01
(-0.66%)
After-Hours: 20:00
Rockwell Medical Profit Margin (Quarterly): -6.84% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -6.84% |
| September 30, 2023 | -7.88% |
| June 30, 2023 | -18.28% |
| March 31, 2023 | -8.90% |
| December 31, 2022 | -12.23% |
| September 30, 2022 | -22.42% |
| June 30, 2022 | -26.59% |
| March 31, 2022 | -44.42% |
| December 31, 2021 | -58.32% |
| September 30, 2021 | -47.42% |
| June 30, 2021 | -55.49% |
| March 31, 2021 | -50.10% |
| December 31, 2020 | -57.13% |
| September 30, 2020 | -48.10% |
| June 30, 2020 | -43.36% |
| March 31, 2020 | -50.35% |
| December 31, 2019 | -47.14% |
| September 30, 2019 | -50.98% |
| June 30, 2019 | -69.33% |
| March 31, 2019 | -55.78% |
| December 31, 2018 | -55.63% |
| September 30, 2018 | -29.81% |
| June 30, 2018 | -82.01% |
| March 31, 2018 | -37.12% |
| December 31, 2017 | -60.92% |
| Date | Value |
|---|---|
| September 30, 2017 | -34.57% |
| June 30, 2017 | -53.48% |
| March 31, 2017 | -32.50% |
| December 31, 2016 | -37.75% |
| September 30, 2016 | -35.61% |
| June 30, 2016 | -39.85% |
| March 31, 2016 | -35.40% |
| December 31, 2015 | -40.83% |
| September 30, 2015 | -16.79% |
| June 30, 2015 | -19.58% |
| March 31, 2015 | -26.64% |
| December 31, 2014 | -44.18% |
| September 30, 2014 | -28.87% |
| June 30, 2014 | -24.33% |
| March 31, 2014 | -60.21% |
| December 31, 2013 | -59.67% |
| September 30, 2013 | -100.9% |
| June 30, 2013 | -91.37% |
| March 31, 2013 | -124.7% |
| December 31, 2012 | -105.2% |
| September 30, 2012 | -140.9% |
| June 30, 2012 | -98.19% |
| March 31, 2012 | -87.85% |
| December 31, 2011 | -75.25% |
| September 30, 2011 | -42.10% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-69.33%
Minimum
Jun 2019
-6.84%
Maximum
Dec 2023
-38.17%
Average
-47.14%
Median
Dec 2019
Profit Margin (Quarterly) Benchmarks
| Cyclacel Pharmaceuticals Inc | -17.00K% |
| Oragenics Inc | -- |
| Alpine Immune Sciences Inc | 19.32% |
| Corvus Pharmaceuticals Inc | -- |
| MAIA Biotechnology Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -53.42% |
| Return on Assets | -18.35% |
| Return on Invested Capital | -33.48% |
| Gross Profit Margin (Quarterly) | 12.99% |
| Operating Margin (Quarterly) | -2.48% |
| Return on Net Operating Assets | -30.11% |